RBC Capital raised the firm’s price target on CyberArk (CYBR) to $481 from $410 and keeps an Outperform rating on the shares. The company posted a strong quarter with all metrics and initial 2025 ...
RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform ...
A coffee shop that’s also a branch of one of the nation’s biggest banks is among the new retail options at a St. Louis-area ...
Brookline Capital Management issued their Q3 2025 earnings estimates for shares of CRISPR Therapeutics in a report released ...
Teradata (NYSE:TDC – Free Report) had its target price cut by Evercore ISI from $37.00 to $32.00 in a research report report ...